Shopping Cart 0
Cart Subtotal
USD 0

Fortis Healthcare Ltd (FORTIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Fortis Healthcare Ltd (Fortis) is an integrated healthcare provider that delivers healthcare services in the Pan Asia-Pacific region. The company's services portfolio comprises diagnostics, primary care, day care and specialty hospitals. It owns, operates, and manages a chain of multi-specialty hospitals and super-specialty centers in India. Fortis's hospitals provide tertiary and quaternary healthcare services to patients primarily in the areas of cardiac care, orthopedics, cancer, neuro sciences, renal care, gastroenterology, renal sciences, and mother and child care, as well as kidney and liver transplants. The company also provides pharmacy items including medical consumables and drugs. It provides healthcare services in India, Dubai, Mauritius and Sri Lanka. Fortis is headquartered in Gurgaon, Haryana, India.

Fortis Healthcare Ltd (FORTIS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Fortis Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Private Equity 12

Avigo Capital Rumored To Invest USD 4 Million In Super Religare Labs 12

Super Religare Labs To Raise USD 67 Million In Private Equity Financing 13

Partnerships 14

Super Religare Labs May Form Joint Venture 14

Fortis Healthcare Enters Into Agreement With Majid Al Futtaim Healthcare To Operate Clinics 15

Equity Offering 16

Super Religare Labs May File for IPO to Raise up to USD100 Million 16

Fortis Healthcare Completes Private Placement Of Shares For USD 6.2 Million 17

Fortis Healthcare Completes Private Placement Of Shares For USD 33 Million 18

Fortis Healthcare Completes Private Placement Of Shares For USD 55 Million 19

Debt Offering 21

Fortis Healthcare Announces Public Offering Of Bonds For USD 30 Million 21

Fortis Healthcare Announces Private Placement Of Bonds For USD 55 Million 22

Asset Transactions 23

Fortis Healthcare To Sell Singapore's Health Business For Upto USD 150 Million 23

Acquisition 24

Yes Bank Acquires 17.31% Stake in Fortis Healthcare 24

Concord Medical to Acquire Fortis Surgical for USD40 Million 25

Netcare and Reliance Foundation May Acquire Sevenhills Healthcare 26

Bupa Completes Acquisition Of Altai Investments From Fortis Healthcare International For USD 355 Million 28

Richard Chandler Completes Acquisition Of 65% Stake In Fortis Hoan My Medical From Fortis Healthcare 29

Bupa Australia Acquires Dental Corporation 30

Royal Bank of Scotland And Jupiter Asset Management Acquire Stake In Fortis Healthcare For USD 3 Million 32

Fortis Healthcare Singapore Acquires 85% Stake In RadLink-Asia For USD 50 Million 33

Fortis Healthcare Completes Acquisition Of Fortis International For USD 665 Million 34

Fortis Healthcare Ltd-Key Competitors 36

Fortis Healthcare Ltd-Key Employees 37

Fortis Healthcare Ltd-Locations And Subsidiaries 38

Head Office 38

Other Locations & Subsidiaries 38

Joint Venture 40

Recent Developments 41

Legal and Regulatory 41

Apr 05, 2018: Fortis to take on Daiichi in case to block its Rs 3,900-crore deal with Manipal Health 41

Mar 02, 2018: Fortis to rope in external agency to investigate inter-corporate deposits 42

Appendix 43

Methodology 43

About GlobalData 43

Contact Us 43

Disclaimer 43


List Of Figure

List of Figures

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Fortis Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Fortis Healthcare Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Fortis Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Avigo Capital Rumored To Invest USD 4 Million In Super Religare Labs 12

Super Religare Labs To Raise USD 67 Million In Private Equity Financing 13

Super Religare Labs May Form Joint Venture 14

Fortis Healthcare Enters Into Agreement With Majid Al Futtaim Healthcare To Operate Clinics 15

Super Religare Labs May File for IPO to Raise up to USD100 Million 16

Fortis Healthcare Completes Private Placement Of Shares For USD 6.2 Million 17

Fortis Healthcare Completes Private Placement Of Shares For USD 33 Million 18

Fortis Healthcare Completes Private Placement Of Shares For USD 55 Million 19

Fortis Healthcare Announces Public Offering Of Bonds For USD 30 Million 21

Fortis Healthcare Announces Private Placement Of Bonds For USD 55 Million 22

Fortis Healthcare To Sell Singapore's Health Business For Upto USD 150 Million 23

Yes Bank Acquires 17.31% Stake in Fortis Healthcare 24

Concord Medical to Acquire Fortis Surgical for USD40 Million 25

Netcare and Reliance Foundation May Acquire Sevenhills Healthcare 26

Bupa Completes Acquisition Of Altai Investments From Fortis Healthcare International For USD 355 Million 28

Richard Chandler Completes Acquisition Of 65% Stake In Fortis Hoan My Medical From Fortis Healthcare 29

Bupa Australia Acquires Dental Corporation 30

Royal Bank of Scotland And Jupiter Asset Management Acquire Stake In Fortis Healthcare For USD 3 Million 32

Fortis Healthcare Singapore Acquires 85% Stake In RadLink-Asia For USD 50 Million 33

Fortis Healthcare Completes Acquisition Of Fortis International For USD 665 Million 34

Fortis Healthcare Ltd, Key Competitors 36

Fortis Healthcare Ltd, Key Employees 37

Fortis Healthcare Ltd, Other Locations 38

Fortis Healthcare Ltd, Subsidiaries 39

Fortis Healthcare Ltd, Joint Venture 40

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Fortis Healthcare Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Fortis Healthcare Ltd (Fortis) is an integrated healthcare provider that delivers healthcare services in the Pan Asia-Pacific region. The company's services portfolio comprises diagnostics, primary care, day care and specialty hospitals. It owns, operates, and manages a chain of multi-specialty hospitals and super-specialty centers in India. Fortis's hospitals provide tertiary and quaternary healthcare services to patients primarily in the areas of cardiac care, orthopedics, cancer, neuro sciences, renal care, gastroenterology, renal sciences, and mother and child care, as well as kidney and liver transplants. The company also provides pharmacy items including medical consumables and drugs. It provides healthcare services in India, Dubai, Mauritius and Sri Lanka. Fortis is headquartered in Gurgaon, Haryana, India.

Fortis Healthcare Ltd (FORTIS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Fortis Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Private Equity 12

Avigo Capital Rumored To Invest USD 4 Million In Super Religare Labs 12

Super Religare Labs To Raise USD 67 Million In Private Equity Financing 13

Partnerships 14

Super Religare Labs May Form Joint Venture 14

Fortis Healthcare Enters Into Agreement With Majid Al Futtaim Healthcare To Operate Clinics 15

Equity Offering 16

Super Religare Labs May File for IPO to Raise up to USD100 Million 16

Fortis Healthcare Completes Private Placement Of Shares For USD 6.2 Million 17

Fortis Healthcare Completes Private Placement Of Shares For USD 33 Million 18

Fortis Healthcare Completes Private Placement Of Shares For USD 55 Million 19

Debt Offering 21

Fortis Healthcare Announces Public Offering Of Bonds For USD 30 Million 21

Fortis Healthcare Announces Private Placement Of Bonds For USD 55 Million 22

Asset Transactions 23

Fortis Healthcare To Sell Singapore's Health Business For Upto USD 150 Million 23

Acquisition 24

Yes Bank Acquires 17.31% Stake in Fortis Healthcare 24

Concord Medical to Acquire Fortis Surgical for USD40 Million 25

Netcare and Reliance Foundation May Acquire Sevenhills Healthcare 26

Bupa Completes Acquisition Of Altai Investments From Fortis Healthcare International For USD 355 Million 28

Richard Chandler Completes Acquisition Of 65% Stake In Fortis Hoan My Medical From Fortis Healthcare 29

Bupa Australia Acquires Dental Corporation 30

Royal Bank of Scotland And Jupiter Asset Management Acquire Stake In Fortis Healthcare For USD 3 Million 32

Fortis Healthcare Singapore Acquires 85% Stake In RadLink-Asia For USD 50 Million 33

Fortis Healthcare Completes Acquisition Of Fortis International For USD 665 Million 34

Fortis Healthcare Ltd-Key Competitors 36

Fortis Healthcare Ltd-Key Employees 37

Fortis Healthcare Ltd-Locations And Subsidiaries 38

Head Office 38

Other Locations & Subsidiaries 38

Joint Venture 40

Recent Developments 41

Legal and Regulatory 41

Apr 05, 2018: Fortis to take on Daiichi in case to block its Rs 3,900-crore deal with Manipal Health 41

Mar 02, 2018: Fortis to rope in external agency to investigate inter-corporate deposits 42

Appendix 43

Methodology 43

About GlobalData 43

Contact Us 43

Disclaimer 43


List Of Figure

List of Figures

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Fortis Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Fortis Healthcare Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Fortis Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Avigo Capital Rumored To Invest USD 4 Million In Super Religare Labs 12

Super Religare Labs To Raise USD 67 Million In Private Equity Financing 13

Super Religare Labs May Form Joint Venture 14

Fortis Healthcare Enters Into Agreement With Majid Al Futtaim Healthcare To Operate Clinics 15

Super Religare Labs May File for IPO to Raise up to USD100 Million 16

Fortis Healthcare Completes Private Placement Of Shares For USD 6.2 Million 17

Fortis Healthcare Completes Private Placement Of Shares For USD 33 Million 18

Fortis Healthcare Completes Private Placement Of Shares For USD 55 Million 19

Fortis Healthcare Announces Public Offering Of Bonds For USD 30 Million 21

Fortis Healthcare Announces Private Placement Of Bonds For USD 55 Million 22

Fortis Healthcare To Sell Singapore's Health Business For Upto USD 150 Million 23

Yes Bank Acquires 17.31% Stake in Fortis Healthcare 24

Concord Medical to Acquire Fortis Surgical for USD40 Million 25

Netcare and Reliance Foundation May Acquire Sevenhills Healthcare 26

Bupa Completes Acquisition Of Altai Investments From Fortis Healthcare International For USD 355 Million 28

Richard Chandler Completes Acquisition Of 65% Stake In Fortis Hoan My Medical From Fortis Healthcare 29

Bupa Australia Acquires Dental Corporation 30

Royal Bank of Scotland And Jupiter Asset Management Acquire Stake In Fortis Healthcare For USD 3 Million 32

Fortis Healthcare Singapore Acquires 85% Stake In RadLink-Asia For USD 50 Million 33

Fortis Healthcare Completes Acquisition Of Fortis International For USD 665 Million 34

Fortis Healthcare Ltd, Key Competitors 36

Fortis Healthcare Ltd, Key Employees 37

Fortis Healthcare Ltd, Other Locations 38

Fortis Healthcare Ltd, Subsidiaries 39

Fortis Healthcare Ltd, Joint Venture 40

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Fortis Healthcare Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.